Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marcela Guadalupe del Carmen, M.D.

Co-Author

This page shows the publications co-authored by Marcela del Carmen and Amy Bregar.
Connection Strength

2.391
  1. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis. Gynecol Oncol. 2017 04; 145(1):114-121.
    View in: PubMed
    Score: 0.696
  2. Initial findings from a prospective, large scale patient reported outcomes program in patients with gynecologic malignancy. Gynecol Oncol. 2022 01; 164(1):113-119.
    View in: PubMed
    Score: 0.242
  3. CT prediction of surgical outcome in patients with advanced epithelial ovarian carcinoma undergoing neoadjuvant chemotherapy. Gynecol Oncol. 2019 03; 152(3):568-573.
    View in: PubMed
    Score: 0.199
  4. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies. Gynecol Oncol. 2018 04; 149(1):4-11.
    View in: PubMed
    Score: 0.189
  5. Intensive care admissions among ovarian cancer patients treated with primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery. Gynecol Oncol. 2017 12; 147(3):612-616.
    View in: PubMed
    Score: 0.182
  6. Minimally Invasive Staging Surgery in Women with Early-Stage Endometrial Cancer: Analysis of the National Cancer Data Base. Ann Surg Oncol. 2017 Jun; 24(6):1677-1687.
    View in: PubMed
    Score: 0.173
  7. Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis. Gynecol Oncol. 2016 Jul; 142(1):38-43.
    View in: PubMed
    Score: 0.165
  8. Patient-reported outcomes and chemotherapy-related cognitive impairment in gynecologic malignancy. Int J Gynecol Cancer. 2022 Feb 15.
    View in: PubMed
    Score: 0.062
  9. Patient reported outcomes after risk-reducing surgery in patients at increased risk of ovarian cancer. Gynecol Oncol. 2022 02; 164(2):421-427.
    View in: PubMed
    Score: 0.061
  10. Lymph node assessment at the time of hysterectomy has limited clinical utility for patients with pre-cancerous endometrial lesions. Gynecol Oncol. 2021 09; 162(3):613-618.
    View in: PubMed
    Score: 0.059
  11. Patient reported outcome measures among patients with vulvar cancer at various stages of treatment, recurrence, and survivorship. Gynecol Oncol. 2021 01; 160(1):252-259.
    View in: PubMed
    Score: 0.056
  12. Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer. Gynecol Oncol. 2018 01; 148(1):168-173.
    View in: PubMed
    Score: 0.046
  13. Associations between residual disease and survival in epithelial ovarian cancer by histologic type. Gynecol Oncol. 2017 11; 147(2):250-256.
    View in: PubMed
    Score: 0.045
  14. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer. Obstet Gynecol. 2017 07; 130(1):71-79.
    View in: PubMed
    Score: 0.045
  15. Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer. Obstet Gynecol. 2017 03; 129(3):439-447.
    View in: PubMed
    Score: 0.044
  16. Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States. Gynecol Oncol. 2016 Nov; 143(2):236-240.
    View in: PubMed
    Score: 0.042
  17. Laparoscopic staging for apparent stage I epithelial ovarian cancer. Am J Obstet Gynecol. 2017 Jan; 216(1):50.e1-50.e12.
    View in: PubMed
    Score: 0.042
  18. Variation in care in concurrent chemotherapy administration during radiation for locally advanced cervical cancer. Gynecol Oncol. 2016 08; 142(2):286-92.
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.